MeSH term
Frequency | Condition_Probility | Adult | 17 | 0.0 |
Arginine/genetics | 2 | 1.0 |
*Body Mass Index | 4 | 4.0 |
Cross-Sectional Studies | 3 | 0.0 |
Female | 22 | 0.0 |
Gene Frequency | 8 | 0.0 |
Genotype | 10 | 0.0 |
Humans | 30 | 0.0 |
Male | 18 | 0.0 |
Middle Aged | 17 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Receptors, Adrenergic, beta-2/*genetics | 2 | 8.0 |
Receptors, Adrenergic, beta-3/*genetics | 8 | 42.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Risk Factors | 3 | 0.0 |
Tryptophan/genetics | 2 | 4.0 |
Blood Glucose/metabolism | 3 | 0.0 |
Heterozygote | 3 | 0.0 |
Homozygote | 2 | 0.0 |
Insulin/blood | 5 | 0.0 |
Insulin Resistance/*genetics | 2 | 2.0 |
Alleles | 4 | 0.0 |
Japan | 2 | 0.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Continental Population Groups | 2 | 1.0 |
Mutation/genetics | 2 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Schizophrenia/*drug therapy | 2 | 6.0 |
Adolescent | 5 | 0.0 |
Aged | 8 | 0.0 |
*Alleles | 2 | 0.0 |
Body Mass Index | 8 | 0.0 |
Body Weight/genetics | 2 | 7.0 |
Obesity/*genetics | 2 | 1.0 |
*Variation (Genetics) | 2 | 0.0 |
Glucose Tolerance Test | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 5 | 0.0 |
Adipose Tissue | 2 | 3.0 |
Case-Control Studies | 3 | 0.0 |
Chromosomes, Human, Pair 8/*genetics | 2 | 1.0 |
Molecular Sequence Data | 4 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
Receptors, Adrenergic, beta-3/genetics | 3 | 50.0 |
Reference Values | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Steroid 21-Hydroxylase/genetics | 2 | 4.0 |
Variation (Genetics) | 2 | 0.0 |
Regression Analysis | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Receptors, Adrenergic, beta/*genetics | 8 | 42.0 |
Body Weight/*genetics | 2 | 13.0 |
Phenotype | 3 | 0.0 |
Receptors, Adrenergic, beta-3 | 5 | 38.0 |
Linkage (Genetics) | 3 | 0.0 |
Blood Glucose/analysis | 2 | 0.0 |
Pedigree | 3 | 0.0 |
Base Sequence | 3 | 0.0 |